These findings although were of limited clinical relevance due to their sole reliability upon total EGFR levels and without any consideration of the receptor activation, did highlight the clinical significance of the EGFR expression in evaluating cancer risk assessment and clinical management. This evidence concerns the gene EGFR and cancer.